Lantheus (LNTH)

• Market cap: $3.61B
• 1 day: 2.12%
• 5 days: -10.8%
• 1 month: -0.16%
• 3 months: 1.11%
• 6 months: -31.46%
• Year to date: -38.63%
• 1 year: -36%
• 5 years: 372.68%
• 10 years: 1,337.99%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Employees: 808